Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3051-3060

  Skrobuk, P ^a,b,c   Von Kraemer, S ^a,b,c   Semenova, M M ^a,b,c   Zitting, A ^a,b,c   Koistinen, H A ^a,b,c  

^a MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

AICAR; AMPK; ERstress; Insulin resistance; Primary human myotubes; Resveratrol

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE BETA; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 2ALPHA; PALMITIC ACID; RESVERATROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RESISTANCE; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; DRUG INTERACTIONS; ENZYME INHIBITORS; GLUCOSE; GLYCOGEN; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; PALMITATES; PHOSPHORYLATION; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; STILBENES;

EID: 84867580794     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2691-1     Document Type: Article

References (42)

1. Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18:139-143
2. McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770
3. Opie LH, Walfish PG (1963) Plasma free fatty acid concentrations in obesity. N Engl J Med 268:757-760
4. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G (1999) Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells. Palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 266:17-25
5. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101-109
6. Chavez JA, Knotts TA, Wang LP et al (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
7. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW (1998) Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47:1121-1126
8. Thrush AB, Heigenhauser GJ, Mullen KL, Wright DC, Dyck DJ (2008) Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans. Am J Physiol Regul Integr Comp Physiol 294:R1205-R1212
9. Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipidinduced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011
10. Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: Mechanisms induced by lipid oversupply. Cell Signal 12:583-594
11. Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19:235-241
12. Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612-622
13. Um JH, Park SJ, Kang H et al (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59:554-563
14. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127:1109-1122
15. Canto C, Jiang LQ, Deshmukh AS et al (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11:213-219
16. Zhang BB, Zhou G, Li C (2009) AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9:407-416
17. Osler ME, Zierath JR (2008) Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 149:935-941
18. Kuoppamaa H, Skrobuk P, Sihvo M et al (2008) Globular adiponectin stimulates glucose transport in type 2 diabetic muscle. Diabetes Metab Res Rev 24:554-562
19. Skrobuk P, Kuoppamaa H, Hiukka A, Koistinen HA (2010) Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle. Metabolism 59:224-230
20. Al-Khalili L, Chibalin AV, Kannisto K et al (2003) Insulin action in cultured human skeletal muscle cells during differentiation: Assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60:991-998
21. Somwar R, Sweeney G, Ramlal T, Klip A (1998) Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. Clin Ther 20:125-140
22. Rune A, Salehzadeh F, Szekeres F, Kuhn I, Osler ME, Al-Khalili L (2009) Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women. Acta Physiol (Oxf) 197:207-215
23. Zhou G, Myers R, Li Yet al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
24. Bouzakri K, Austin R, Rune A et al (2008) Malonyl coenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle. Diabetes 57:1508-1516
25. Wojtaszewski JF, Birk JB, Frosig C, Holten M, Pilegaard H, Dela F (2005) 5'AMP activated protein kinase expression in human skeletal muscle: Effects of strength training and type 2 diabetes. J Physiol 564:563-573
26. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529
27. Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61
28. Baur JA, Pearson KJ, Price NL et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342
29. Su HC, Hung LM, Chen JK (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocininduced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-E1346
30. Sun C, Zhang F, Ge X et al (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6:307-319
31. Zang M, Xu S, Maitland-Toolan KA et al (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55:2180-2191
32. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007
33. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76:149-155
34. Breen DM, Sanli T, Giacca A, Tsiani E (2008) Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 374:117-122
35. Minakawa M, Kawano A, Miura Y, Yagasaki K (2011) Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic ß-cells. J Clin Biochem Nutr 48:237-244
36. Hawley JA, Burke LM, Phillips SM, Spriet LL (2011) Nutritional modulation of training-induced skeletal muscle adaptations. J Appl Physiol 110:834-845
37. Fröjdö S, Cozzone D, Vidal H, Pirola L (2007) Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 406:511-518
38. Zhang J (2006) Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397:519-527
39. Fröjdö S, Durand C, Molin L et al (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 335:166-176
40. Park JB (2001) Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells. J Nat Prod 64:381-384
41. Park S-J, Ahmad F, Philp A et al (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421-433
42. Hwang S-L, Chang H-W, Lee I-K, Yang B-K, Magae J, Chang Y-C (2010) Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells. Biochem Biophys Res Commun 396:967-972